A CLINICAL STUDY TO EVALUATE ROLE OF AYURVEDIC MANAGEMENT FOR IMPROVING ACTIVITIES OF DAILY LIVING IN CEREBRAL PALSY AFFECTED CHILDREN by Kuldeep R, Choudhary & Kumar, Abhimanyu
 Int. J. Ayur. Pharma Research, 2014; 2(4): 68-82  ISSN: 2322 - 0910 
 
 Available online at : http://ijapr.in Page 68 
International Journal of Ayurveda and Pharma Research  
                                             Research Article 
 
A CLINICAL STUDY TO EVALUATE ROLE OF AYURVEDIC MANAGEMENT FOR IMPROVING 
ACTIVITIES OF DAILY LIVING IN CEREBRAL PALSY AFFECTED CHILDREN 
Choudhary Kuldeep R1*, Abhimanyu Kumar2 
*1Lecturer, Sri Satya Sai Murlidhar Ayurvedic college and Hospital, Moga, Punjab, India. 
2Professor and Director, All India Institute of Ayurveda, New Delhi. India. 
Received on: 22/07/2014   Revised on: 10/08/2014               Accepted on: 26/08/2014 
ABSTRACT  
Background: Cerebral palsy is disorder of neuromotor origin due to non progressive 
brain damage in its early developing period. It is often accompanied by other features 
like seizures, behavioral disorders and cognitive impairment restricting their normal 
activities of daily living, making them to be dependent on others. Aim and Objectives: 
The present clinical study was designed with an aim to improve quality of life and 
establish optimal independence in activities of daily living (ADL) by potentiating the 
effects of world widely accepted Physiotherapy treatment along with Ayurvedic modality 
for better management of Cerebral palsy with a ray of new hope. Material and Methods: 
The study was performed on forty five patients of age group one to twelve years of either 
sex. Patients were therapeutically randomized into three groups and received treatment 
for six months. Group A (n=14) received Physiotherapy; Group B (n=14) was treated 
with Physiotherapy and Ayurvedic procedures while Group C (n=14) received 
Physiotherapy, Ayurvedic procedures and Syp. Ayurvedic compound. Out of forty five 
cases, three of them discontinued treatment. Parameters for assessment were based on 
standard guidelines of Activities of daily living – Modified Barthel score. Results: The 
effect of therapy observed on total ADL score at end of six months was statistically 
significant (p<0.05) in Group A with a gain of 58.41% while in Group B and C it was 
statically highly significant (p<0.001) with gain of 62.80% and 62.68% respectively. 
Conclusion: The improvement noted in Group B and C was enhanced by effects of 
Ayurvedic procedures and Syp. Ayurvedic compound due to improvement in muscle tone, 
gain in muscle strength, proper nourishment of Dhatus and intelligence for better skilled 
performance. 
KEY WORDS : Cerebral palsy, Physiotherapy, Ayurvedic management, ADL. 
INTRODUCTION 
Cerebral palsy (CP) is defined as non 
progressive disorder of movement and posture 
caused by insult or injury to developing brain 
during its early stage of development. Being 
predominantly motor disorder it is often 
accompanied by cognitive impairment, seizures 
and extra pyramidal abnormalities. The data 
about its prevalence and relationship to 
etiological factor is very scanty in our country. 
Although the overall prevalence rate is 2.5 per 
1000 but may vary from 1 to 6 per 1000.[1,2] The 
condition poses considerable diagnostic and 
therapeutic challenge to the treating physician. 
The disability restrains the child’s ability to 
perform normal activities of daily living thereby 
rendering him/her to be dependent on others for 
their needs.  
Management of CP in children requires 
multidisciplinary approach. Physiotherapy is 
accepted worldwide as standard for 
rehabilitation procedure. Medical management 
of spasticity, seizures etc. are associated with 
minimal effects.  
There is no specific disorder similar to 
CP mentioned in Ayurvedic texts. Much 
information regarding the different aspects of 
this condition is found scattered in the various 
context of antenatal, natal and postnatal care. 
Based on above information and the clinical 
manifestations, it may be considered that CP is a 
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is a disorder of Vata predominance manifesting 
all over body with site of lesion in Mastishka 
(Brain), in form of Monoplegia (Ekanga Vata), 
Hemiplegia (Pakshaghata), Diplegia (Pangu), 
Quadriplegia (Sarvanga Vata) etc. As the 
Mastishka or Shira pradesh is the location of 
Gyanendriya and Karmanendriya. So the feature 
of Gyanendriyakarmahani (loss of sensation of 
sensory organs) are usually accompanied with 
motor involvement (Karmenendriya). The 
involvement of Chaksu – indriya leads to 
Andhata(optical/ cortical blindess), Vikrut dusthi 
(Squint, strabismus), refractive errors etc. The 
involvement of Shotra – indriya leads to Badhirya 
(sensorineural deafness) and Sparsha – Indriya 
leads to loss of perception of sensations. The 
higher functions of brain like Buddhi is also 
affected ranging from mild to severe Mental 
retardation. 
Keeping in view of Doshic and sub-doshic 
involvement, the treatment was formulated with 
consideration of Ayurvedic procedures like 
Abhyanga, Shastik Sali Pinda Sweda, Matra basti 
and Shirodhara along with oral compound 
containing ingredients with predominantly 
properties of Medhya, Balya, Brimhana and 
Vatahara. The principle was to bring out 
normalcy of vitiated Dosha, providing better 
nourishment to Dhatus and to compensate for 
brain damage up to certain extent with concept 
of regenerating neurons and improving 
cognition. 
AIMS AND OBJECTIVES 
 To improve quality of life in CP affected 
children. 
 Early rehabilitation to improve the 
functional capacity of the child. 
 To reduce spasticity, deformities and to 
prevent development of contractures. 
 To establish optimal independence in daily 
life activities by learning skilled movement. 
MATERIAL AND METHODS 
For the present clinical study total 45 
cases of diagnosed CP patients (irrespective of 
type and cause) were selected from O.P.D and 
I.P.D of Balroga, National institute of Ayurveda 
(Jaipur) from year 2008-11. Duration of the trail 
was for six months. Out of them 3 cases did not 
turn up for complete follow up hence were 
dropped out from the study and were completed 
in 42 patients.  
Selected patients were therapeutically 
randomized into three groups. Group A receiving 
Physiotherapy treatment, Group B receiving 
Physiotherapy and Panchkarma procedures and 
Group C receiving Panchkarma procedures, Syp. 
Ayurvedic compound and Physiotherapy. In each 
Group A, B and C 14 patients managed to 
complete their trial for 6 month duration. 
Criteria Adopted 
1. Inclusion criteria:  Age group one to twelve 
years of either sex.  
2. Exclusion Criteria:  Individuals below one 
years and above twelve years of age. 
Progressive neurologic disorders. 
3. Discontinuation Criteria: Parents / 
guardian not willing to continue treatment. 
Patients who develop life threatening 
complication during treatment. 
4. Assessment Criteria for ADL: Modified 
Barthel Score. [3] 
Table 1: Modified Barthel Index 
Item Unable to 
perform task 
Attempt task 
but unsafe 
Moderate 
help required 
Minimal help 
required 
Fully 
Independent 
Personal hygiene 0 1 3 4 5 
Bathing self 0 1 3 4 5 
Feeding 0 2 5 8 10 
Toilet 0 2 5 8 10 
Stair Climbing 0 2 5 8 10 
Dressing 0 2 5 8 10 
Bowel control 0 2 5 8 10 
Bladder control 0 2 5 8 10 
Ambulation 
(wheel chair) 
0 
(0) 
3 
(1) 
8 
(3) 
12 
(4) 
15 
(5) 
Chair – bed 
transfer 
0 3 8 12 15 
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A. Trial Compound 
Syp. Ayurvedic compound – A compound 
containing eleven herbs were selected for the 
present study. It was prepared by the institute 
pharmacy in the form of syrup for making it 
palatable. 
Method of preparation of Study drug - All the 
ingredients were taken in the quantities 
mentioned in table no.2. After making their 
coarse powder, the powder was soaked in water 
for one night. Later on coarse powder of the 
drugs was boiled after adding water (8 times 
than powder), till it remained 1/8 of total 
quantity. Then sugar was added to decoction and 
boiled for 30 min., after that the preparation was 
allowed to cool. Then preservatives were added 
in the preparation. At last, flavor and color were 
added. 
Presentation - The drug was packed and sealed 
in sterile, airtight, each 200 ml quantity glass 
bottles labeled with date of manufacture and 
batch no. 
Table no. 2: Ingredients of Syp. Ayurvedic compound 
S. 
No 
Drug name Botanical name Part used Proportion 
1. Brahmi  Bacopa monnieri (L.) Pennell. Panchanga  1 part  
2. Mandookparni Centella asiatica (L.)Urban Panchanga  1 part  
3. Vacha Acorus calamus L. Root  ¼ part 
4. Jatamansi Nardostachys jatamansi DC. Rhizome  ½ part 
5. Ashwagandha Withania somnifera Dunal Root  1 part 
6. Madhuyasthi Glycyrrhiza glabra L. Root  1 part  
7. Bala Sida cordifolia L. Root  1 part  
8. Guduchi Tinospora cordifolia (Willd.) 
Hook.F. & Thoms. 
Stem  1 part 
9. Vidarikanda Pueraria tuberosa (Roxb. Ex. 
Willd.) Dc. 
Tubers  1 part  
10. Kapikacchu Mucuna pruriens (L.) DC Seed ½ part 
11. Pippali Piper longum L. Fruit, Root  ¼ part  
Drug dose and duration: Doses were calculated according to the body weight of the child 
(1ml/kg/day) in three divided doses for six months. Children were called for follow up after every 30 
days. Any discomfort or untoward side effects were noticed.  
B. Panchkarma Procedures - The procedures applied during the course of treatment were 
Table 3: Procedures applied during study and their respective duration 
Procedures Ingredients / 
Medications 
Duration of therapy (Same for all age group) 
Abhyanga Kshirbala Taila 15 mins. per day continuously for six months 
Shastik Sali 
pinda sweda 
Shastik Sali, Balamula 
kwatha and Godugdha 
30 mins. per day for 21 days continuously 
followed by a rest of 7 days. Such one cycle was 
repeated for 6 times. 
Matra basti Kshirbala taila 10 days continuously once in a 2 month period. 
Such one cycle was repeated for 3 times. 
Shirodhara Balamula kwatha with 
godugdha 
30 mins. per day for 10 days continuously once in 
a 2 month period. Such one cycle was repeated for 
3 times. 
C. Physiotherapy – A set of exercise containing 
passive and gentle stretching was performed on 
individual joints. It was also carried out coupled 
with Abhyanga once in a day in form of repetitive 
passive range of motion exercises to improve 
and maintain joint mobility.  
 
Statistical analysis – By using Students paired 
and unpaired ‘t’ test. 
OBSERVATION AND RESULTS 
The study reported max no. of cases from 
age group 1 – 4 yrs (54.76%), followed by 5 – 8 
yrs (35.71%) & age group 9 – 12 years (8.33%). 
Affected male were 66.66 % & female with 33.34 
Choudhary Kuldeep R et al. Ayurvedic Management for Improving Activities of Cerebral Palsy  
 Available online at : http://ijapr.in Page 71 
%. Among total registered cases 37 were spastic 
(88.10%) in nature followed by 4 (9.52%) cases 
of Hypotonic and 1 (2.38%) case of Dyskinetic. 
Of the total Spastic CP cases, the maximum no of 
patients i.e. 14 (37.83%) were found to be 
Quadriplegic followed by 13 (35.13%) patients 
of Diplegic in nature. 7 (18.91%) cases were 
found to have Hemiplgic pattern, 2 (5.40%) cases 
were Monoplegic and 1 (2.70%) of Double 
hemiplegia in nature. 
Table 4: Showing Effect on Activities of Daily living score in Group A 
Sr. 
no 
Particul
ars 
Duratio
n 
in 
month 
Mean  
BT 
(n =14) 
Mean 
AT 
(n =14) 
Mean 
 Diff 
(n =14) 
% 
change 
S.D. 
(±) 
S.E. 
(±) 
' t ' 
value 
‘ p ' 
value 
Result 
1. Personal 
Hygiene 
2 m 0.2857 0.2857 0 0 0 0 0 - - 
4 m 0.2857 0.4286 0.143 33.36 0.3631 0.0971 1.472 >0.10 In. Sig. 
6 m 0.2857 0.7853 0.5 63.66 1.0919 0.2918 1.713 >0.05 In. Sig. 
2. Bathing 
Self 
2 m 0.7143 0.4615 0 0 0 0 0 - - 
4 m 0.7143 0.8571 0.143 16.684 0.3631 0.0971 1.472 >0.10 In. Sig. 
6 m 0.7143 01.2143 0.5 41.175 0.8549 0.2285 2.188 <0.05 Sig. 
3. Feeding 2 m 1.2857 1.0769 0 0 0 0 0 - - 
4 m 1.2857 1.7143 0.429 25.024 1.0894 0.2912 1.472 >0.10 In. Sig. 
6 m 1.2857 2.3571 1.071 45.437 1.3281 0.3549 3.019 < 0.01 Sig. 
4. Toilet 2 m 0.7143 0.8571 0.143 16.684 0.5345 0.1429 1.0 >0.10 In. Sig. 
4 m 0.7143 1.0714 0.357 33.320 0.9288 0.2482 1.439 >0.10 In. Sig. 
6 m 0.7143 1.2857 0.571 44.411 1.5046 0.4021 1.421 >0.10 In. Sig. 
5. Stair 
climbing 
2 m 0.5714 0.5714 0 0 0 0 0 - - 
4 m 0.5714 0.8571 0.286 33.368 0.7263 0.1941 1.472 >0.10 In. Sig. 
6 m 0.5714 1.2857 0.714 55.533 1.8157 0.4853 1.472 >0.10 In. Sig. 
6. Dressing 2 m 0.8571 0.8571 0 0 0 0 0 - - 
4 m 0.8571 1.0 0.143 14.3 0.5345 0.1429 1.0 >0.10 In. Sig. 
6 m 0.8571 1.5714 0.714 45.437 1.2044 0.3219 2.129 >0.05 In. Sig. 
7. Bowel 
control 
2 m 0.8571 1.0 0.143 14.3 0.5345 0.1429 1.0 >0.10 In. Sig. 
4 m 0.8571 1.3571 0.5 36.843 1.019 0.2724 1.836 >0.05 In. Sig. 
6 m 0.8571 2.2143 1.357 61.283 2.3074 0.6167 2.201 <0.05 Sig. 
8. Bladder 
control 
2 m 0.8571 1.0 0.143 14.3 0.5345 0.1429 1.0 >0.10 In. Sig. 
4 m 0.8571 1.3571 0.5 36.843 1.019 0.2724 1.836 >0.05 In. Sig. 
6 m 0.8571 2.2143 1.357 61.283 2.3074 0.6167 2.201 <0.05 Sig. 
9. Ambulati
on 
2 m 1.0 1.0 0 0 0 0 0 - - 
4 m 1.0 1.9286 0.929 48.169 1.9 0.5078 1.829 >0.05 In. Sig. 
6 m 1.0 2.1429 1.143 53.338 1.9556 0.5229 2.187 <0.05 Sig. 
10. Chair bed 
transfer 
2 m 0.7857 0.7857 0 0 0 0 0 - - 
4 m 0.7857 1.0 0.214 21.4 0.8018 0.2143 1.0 >0.10 In. Sig. 
6 m 0.7857 1.2143 0.429 35.328 1.0894 0.2912 1.472 >0.10 In. Sig. 
11. Total 
score 
2 m 7.9286 8.1429 0.214 2.628 1.4769 0.3947 0.543 >0.10 In. Sig. 
4 m 7.9286 11.571 3.643 31.483 6.6749 1.784 2.042 >0.05 In. Sig. 
6 m 7.9286 19.071 11.14 58.413 15.084 4.0313 2.764 <0.02 Sig. 
(Sig. – significant; H.Sig – highly significant; In.sig –insignificant) 
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Table 5: Showing Effect on Activities of Daily living score in Group B 
S. 
no 
Particul
ars 
Duration 
In month 
Mean BT 
(n=14) 
Mean AT 
(n=14) 
Mean diff 
(n =14) 
% 
change 
S.D. 
(±) 
S.E. 
(±) 
' t ' 
value 
‘ p ' 
value 
Result 
1. Personal 
Hygiene 
2 m 0.5 0.5714 0.0714 12.495 0.2672 0.0714 1.0 >0.10 In. Sig. 
4 m 0.5 1.0714 0.571 53.294 0.7559 0.202 2.828 <0.02 Sig. 
6 m 0.5 1.8571 1.357 73.070 1.1507 0.3075 4.413 <0.001 H. Sig. 
2. Bathing 
Self 
2 m 1.2143 1.2143 0 0 0 0 0 - - 
4 m 1.2143 1.9286 0.714 37.021 0.9139 0.2442 2.924 <0.02 Sig. 
6 m 1.2143 2.3571 1.143 48.491 0.9493 0.2537 4.505 <0.001 H. Sig. 
3. Feeding 2 m 2.3571 2.3571 0 0 0 0 0 - - 
4 m 2.3571 3.5714 1.214 33.992 1.4769 0.3947 3.076 <0.01 Sig. 
6 m 2.3571 4.5714 2.214 48.431 1.2514 0.3344 6.621 <0.001 H. Sig. 
4. Toilet 2 m 0.5714 0.7143 0.1429 20.005 0.5345 0.1428 1.0 >0.10 In. Sig. 
4 m 0.5714 1.4286 0.857 59.988 1.2315 0.3291 2.604 <0.05 Sig. 
6 m 0.5714 2.7857 2.214 79.477 2.0821 0.5565 3.979 <0.01 Sig. 
5. Stair 
climbing 
2 m 0.5714 0.7857 0.2143 27.275 0.8017 0.2142 1.0 >0.10 In. Sig. 
4 m 0.5714 1.2857 0.714 55.533 1.2044 0.3219 2.219 <0.05 Sig. 
6 m 0.5714 2.1429 1.571 73.311 1.989 0.5316 2.956 <0.02 Sig. 
6. Dressing 2 m 0.7143 0.8571 0.1429 16.672 0.534 0.1428 1.0 >0.10 In. Sig. 
4 m 0.7143 1.6429 0.929 56.546 1.3281 0.3549 2.616 <0.05 Sig. 
6 m 0.7143 2.9286 2.214 75.599 1.8472 0.4937 4.485 <0.001 H. Sig. 
7. Bowel 
control 
2 m 1.7857 1.9286 0.1429 7.409 0.534 0.1428 1.0 >0.10 In. Sig. 
4 m 1.7857 2.9286 1.143 39.028 1.4064 0.3759 3.04 <0.01 Sig. 
6 m 1.7857 4.2857 2.5 58.333 1.286 0.3437 7.274 <0.001 H. Sig. 
8. Bladder 
control 
2 m 1.7857 1.9286 0.1429 7.409 0.5345 0.1428 1.0 >0.10 In. Sig. 
4 m 1.7857 2.9286 1.143 39.028 1.4064 0.3759 3.04 <0.01 Sig. 
6 m 1.7857 4.2857 2.5 58.333 1.286 0.3437 7.274 <0.001 H. Sig. 
9. Ambulati
on 
2 m 1.6429 1.6429 0 0 0 0 0 - - 
4 m 1.6429 3.0714 1.429 46.526 2.0649 0.5519 2.589 <0.05 Sig. 
6 m 1.6429 4 2.357 58.92 2.2398 0.5986 3.938 <0.01 Sig. 
10. Chair bed 
transfer 
2 m 1 1 0 0 0 0 0 - - 
4 m 1 1.7143 0.714 41.649 1.4373 0.3841 1.859 >0.05 In. Sig. 
6 m 1 3.4286 2.429 70.845 2.5333 0.6771 3.587 <0.01 Sig. 
11. Total 
score 
2 m 12.14 13 -0.8571 6.59 1.561 0.417 2.053 >0.05 In. Sig. 
4 m 12.14 22.28 -10.41 46.72 10.21 2.729 3.71 <0.01 Sig. 
6 m 12.14 32.64 -20.5 62.80 13.17 3.521 5.82 <0.001 H. Sig. 
(Sig. – significant; H.Sig – highly significant; In.sig –insignificant) 
 
 
Choudhary Kuldeep R et al. Ayurvedic Management for Improving Activities of Cerebral Palsy  
 Available online at : http://ijapr.in Page 73 
Table 6: Showing Effect on Activities of Daily living score in Group C 
Sr. 
No 
Particula
rs 
Duratio
n 
in 
month 
Mean 
BT 
(n=14) 
Mean 
AT 
(n=14) 
Mean 
diff 
(n=14) 
% 
Change 
S.D. 
(±) 
S.E. 
(±) 
' t ' 
value 
‘ p ' 
value 
Result 
1. Personal 
Hygiene 
2 m 0.7143 0.7857 0.071 9.036 0.2673 0.0714 1.0 >0.10  In. Sig. 
4 m 0.7143 1.5 0.786 52.4 0.8926 0.2386 3.294 <0.01  Sig. 
6 m 0.7143 2 1.286 64.3 1.069 0.2857 4.5 <0.001  H. Sig. 
2. Bathing 
Self 
2 m 1.5714 1.8571 0.286 15.400 0.6112 0.1634 1.749 >0.10  In. Sig. 
4 m 1.5714 2.4286 0.857 35.287 0.7703 0.2059 4.163 <0.001  H. Sig. 
6 m 1.5714 3.0714 1.5 48.837 1.019 0.2724 5.508 <0.001  H. Sig. 
3. Feeding 2 m 2.7143 2.8571 0.143 5.005 0.5345 0.1429 1.0 >0.10  In. Sig. 
4 m 2.7143 4.1429 1.429 34.492 1.5046 0.4021 3.553 <0.01  Sig. 
6 m 2.7143 5.4286 2.714 49.994 1.4373 0.3841 7.066 <0.001  H. Sig. 
4. Toilet 2 m 1.2143 1.2143 0 0 0 0 0 - - 
4 m 1.2143 2.5714 1.357 52.7723 1.4469 0.3867 3.51 <0.01  Sig. 
6 m 1.2143 3.7857 2.571 67.913 2.5027 0.6689 3.844 <0.01  Sig. 
5. Stair 
climbing 
2 m 0.9286 1.2143 0.286 23.552 0.7263 0.1941 1.472 >0.10  In. Sig. 
4 m 0.9286 2.0 1.071 53.55 1.3281 0.3549 3.019 <0.01  Sig. 
6 m 0.9286 3.4286 2.5 72.916 2.5038 0.6692 3.736 <0.01  Sig. 
6. Dressing 2 m 1.4286 1.7143 0.286 16.683 0.7263 0.1941 1.472 >0.10  In. Sig. 
4 m 1.4286 2.7857 1.357 48.713 1.4469 0.3867 3.51 <0.01  Sig. 
6 m 1.4286 4.1429 2.714 65.509 2.1989 0.5877 4.619 <0.001  H Sig. 
7. Bowel 
control 
2 m 2.0 2.1429 0.143 6.673 0.5345 0.1429 1.0 >0.10  In. Sig. 
4 m 2.0 3.3571 1.357 40.42 1.4469 0.3867 3.51 <0.01  Sig. 
6 m 2.0 5.0714 3.071 60.555 1.4917 0.3987 7.704 <0.001  H. Sig. 
8. Bladder 
control 
2 m 2.0 2.1429 0.143 6.673 0.5345 0.1429 1.0 >0.10  In. Sig. 
4 m 2.0 3.3571 1.357 40.421 1.4469 0.3867 3.51 <0.01  Sig. 
6 m 2.0 5.0714 3.071 60.555 1.4917 0.3987 7.704 <0.001  H Sig. 
9. Ambulatio
n 
2 m 2.0 2.2143 0.214 9.664 0.8018 0.2143 1.0 >0.10  In. Sig. 
4 m 2.0 3.5714 1.571 43.988 2.1381 0.5714 2.75 <0.02  Sig. 
6 m 2.0 5.0714 3.071 60.555 2.5257 0.675 4.55 <0.001  H. Sig. 
10. Chair bed 
transfer 
2 m 0.7857 1.4286 0.643 45.009 1.2774 0.3414 1.883 <0.10  In. Sig. 
4 m 0.7857 2.2143 1.429 64.535 1.7852 0.4771 2.994 <0.01 Sig. 
6 m 0.7857 4.1429 3.357 81.030 3.4776 0.9294 3.612 <0.01 Sig. 
11. Total 
score 
2 m 15.357 17.571 2.214 12.600 3.6623 0.9788 2.262 <0.05 Sig. 
4 m 15.357 27.929 12.57 45.006 10.234 2.735 4.596 <0.001 H. Sig. 
6 m 15.357 41.143 25.79 62.683 15.582 4.1644 6.192 <0.001 H. Sig. 
(Sig. – significant; H.Sig – highly significant; In.sig –insignificant) 
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Table 7: Showing effect on Activities of Daily living score - Inter group (Pre) comparison at end 
of six month duration 
Sr. 
No 
Particulars Inter Group 
comparison 
Mean diff 
(n = 28) 
S.D. 
(±) 
S.E. 
(±) 
' t26 ' 
Value 
‘ p ' 
Value 
Result 
1. Personal 
Hygiene 
A – B -0.214 0.9678 0.36583 0.5858 >0.10 In.Sig 
A – C -0.429 1.06904 0.4040 1.0607 >0.10 In.Sig 
B – C -0.214 0.9678 0.3658 0.5858 >0.10 In.Sig 
2. Bathing Self A – B -0.5 1.3475 0.5093 0.9817 >0.10 In.Sig 
A – C -0.857 1.4713 0.55611 1.5413 >0.10 In.Sig 
B – C -0.357 1.3837 0.5230 0.6828 >0.10 In.Sig 
3. Feeding A – B -1.071 2.45 0.926 1.157 >0.10 In.Sig 
A – C -1.429 2.447 0.9249 1.544 >0.10 In.Sig 
B – C -0.357 2.202 0.8322 0.429 >0.10 In.Sig 
4. Toilet A – B 0.1429 1.667 0.6302 0.226 >0.10 In.Sig 
A – C -0.5 1.8523 0.7 0.714 >0.10 In.Sig 
B – C -0.643 1.237 0.467 1.374 >0.10 In.Sig 
5. Stair Climbing A – B 0 1.650 0.623 0 >0.10 In.Sig 
A – C -0.357 1.843 0.6967 0.512 >0.10 In.Sig 
B – C -0.357 1.245 0.4709 0.7584 >0.10 In.Sig 
6. Dressing A – B 0.1429 1.6935 0.6401 0.2231 >0.10 In.Sig 
A – C -0.571 1.991 0.7528 0.7591 >0.10 In.Sig 
B – C -0.714 1.444 0.5461 1.3079 >0.10 In.Sig 
7. Bowel Control A – B -0.929 2.076 0.7847 1.183 >0.10 In.Sig 
A – C -1.143 2.1636 0.8177 1.3975 >0.10 In.Sig 
B – C -0.214 2.0602 0.7786 0.2752 >0.10 In.Sig 
8. Bladder 
Control 
A – B -0.929 2.076 0.7847 1.183 >0.10 In.Sig 
A – C -1.143 2.1636 0.8177 1.3975 >0.10 In.Sig 
B – C -0.214 2.0602 0.7786 0.2752 >0.10 In.Sig 
9. Ambulation A – B -0.643 2.3139 0.8745 0.735 >0.10 In.Sig 
A – C -1.0 2.601 0.9833 1.016 >0.10 In.Sig 
B – C -0.357 2.6254 0.9923 0.3599 >0.10 In.Sig 
10. Chair bed 
transfer 
A – B -0.214 2.2562 0.8527 0.251 >0.10 In.Sig 
A – C 0 2.224 0.840 0 >0.10 In.Sig 
B – C 0.2143 2.2562 0.8527 0.2512 >0.10 In.Sig 
11. Total effect A – B - 4.214 17.1 6.463 0.652 >0.10 In.Sig 
A – C - 7.429 18.407 6.9575 1.0677 >0.10 In.Sig 
B – C - 3.214 15.30 5.7850 0.555 >0.10 In.Sig 
(Sig. – significant; H.Sig – highly significant; In.sig –insignificant) 
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Table 8: Showing effect on Activities of Daily living score - Inter group (Post) comparison at end 
of six month duration 
Sr. 
No 
Particulars Inter Group 
comparison 
Mean diff 
(n = 28) 
S.D. 
 
S.E. 
(±) 
' t26 ' 
Value 
‘ p ' 
Value 
Result 
1. Personal 
Hygiene 
A – B -1.071 1.5941 0.602 1.778 >0.05 In.Sig. 
A – C -1.214 1.69112 0.6391 1.899 >0.05 In.Sig. 
B – C -0.143 1.6608 0.6277 0.227 >0.10 In.Sig. 
2. Bathing Self A – B -1.143 1.7272 0.6528 1.7506 >0.05 In.Sig. 
A – C -1.857 1.873 0.7082 2.6223 <0.02 Sig. 
B – C -0.714 1.882 0.7115 1.003 >0.10 In.Sig. 
3. Feeding A – B -2.429 3.1596 1.1942 2.033 >0.05 In.Sig. 
A – C -3.071 2.9912 1.1306 2.716 >0.02 Sig. 
B – C -0.643 3.197 1.208 0.532 >0.10 In.Sig. 
4. Toilet A – B -1.5 2.654 1.003 1.495 >0.05 In.Sig. 
A – C -2.5 3.083 1.165 2.145 <0.05 Sig. 
B – C -1.0 3.092 1.169 0.8554 >0.10 In.Sig. 
5. Stair 
Climbing 
A – B -0.857 2.5158 0.9509 0.9014 >0.10 In.Sig. 
A – C -2.143 3.151 1.191 1.798 >0.05 In.Sig. 
B – C -1.286 3.045 1.151 1.117 >0.10 In.Sig. 
6. Dressing A – B -1.357 2.803 1.059 1.280 >0.10 In.Sig. 
A – C -2.571 3.083 1.165 2.206 <0.05 Sig. 
B – C -1.214 2.859 1.080 1.123 >0.10 In.Sig. 
7. Bowel 
Control 
A – B -2.071 2.982 1.127 1.837 >0.05 In.Sig. 
A – C -2.857 2.982 1.127 2.534 <0.02 Sig. 
B – C -1.071 2.730 1.031 0.7614 >0.10 In.Sig. 
8. Bladder 
Control 
A – B -2.071 2.982 1.127 1.837 >0.05 In.Sig. 
A – C -2.857 2.982 1.127 2.534 <0.02 Sig. 
B – C -1.071 2.730 1.031 0.7614 >0.10 In.Sig. 
9. Ambulation A – B -1.857 3.709 1.401 1.324 >0.10 In.Sig. 
A – C -2.929 3.983 1.505 1.944 >0.05 In.Sig. 
B – C -1.071 4.291 1.622 0.6605 >0.10 In.Sig. 
10. Chair bed 
transfer 
A – B -2.214 3.2686 1.2354 1.792 >0.05 In.Sig. 
A – C -2.929 3.464 1.309 2.236 <0.05 Sig. 
B – C -0.714 4.156 1.570 0.4547 >0.10 In.Sig. 
11. Total effect A – B -13.57 25.39 9.597 1.414 >0.10 In.Sig. 
A – C -22.07 27.245 10.297 2.143 <0.05 Sig. 
B – C -8.5 27.210 10.284 0.8265 >0.10 In.Sig. 
(Sig. – significant; H. Sig – highly significant; In. sig –insignificant) 
The overall effect of treatment observed 
on total ADL score in Group A at end of 2 & 4 
months showed improvement which was 
statistically insignificant (p > 0.10 & p>0.05) 
with gain of 2.62% and 31.48% respectively 
while at the end of 6 months the improvement 
noted was statistically significant (p<0.05) with 
gain of 58.41% (Table no.3). The result obtained 
in Group B at end of 2 months showed 
improvement to be statistically insignificant (p 
>0.05) with gain of 6.59%. The improvement 
noted at 4 and 6 month was statistically 
significant (p < 0.01) and highly significant 
(p<0.001) with gain of 46.72% and 62.80% 
respectively (Table no.4). The effect observed in 
Group C at 2 months showed improvement 
which was statistically significant (p<0.05) with 
gain of 12.60%. The improvement noted at 4 and 
6 months was statistically Highly significant 
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(p<0.001) with gain of 45% and 62.68% 
respectively (Table no.5). 
Before analyzing the effectiveness of 
treatment of one group over the other, the Mean 
BT of both Inter groups were compared by using 
Unpaired‘t’ test to check the uniformity of 
sample. The inter Group difference analyzed in 
all three inter groups showed statistically 
insignificant result (p>0.10) which indicates 
uniformity of sample size. (See table no. 6) The 
Mean AT of both Inter groups were compared by 
using Unpaired‘t’ test. 
The post inter group difference test in 
Group A – B shows that Group B had advantage 
over Group A which was statistically insignificant 
(p>0.10) while in Group A – C, the Group C 
showed advantage which was statistically 
significant (p<0.05) whereas in Group B – C the 
result was statistically insignificant (p>0.10). 
(Table no.7) 
DISCUSSION 
The effect of therapy observed on total 
ADL score at end of six months was better in 
Group B and C compared to Group A. Thus it 
signifies the effectiveness of combined approach 
incorporated for better improvement. Similarly, 
in post inter group comparison test Group C 
dominated over Group A marginally to be 
significant.  
The effect achieved in Group C compared 
to Group B may be due to effects of Syp. 
Ayurvedic Compund having Medhya, Balya, 
Brihmana properties. Medhya drugs improve 
cognition because ADL not only requires motor 
function but also certain level of intelligence and 
skill training. Balya and Brihmana drugs helped 
in the proper nourishment and maintenance of 
dhatus. It also requires continuous support or 
their actual participation of parents to make him 
learn. So the result found in this particular test 
cannot be interrelated fully due to lack of large 
sample size. It also depends on the educational 
status of parents how much they are aware of 
this condition and what is their role hence 
counseling also plays pivotal role on parents.  
Probable mode of Action of Trial drug (Syp. 
Ayurvedic compound)  
On evaluation of Ayurvedic 
pharmacodynamical properties, the ingredients 
of Syp. Ayurvedic compound are predominantly 
of Madhura, Tikta, Katu and Kashaya rasa; 
Snigdha, laghu and Guru guna; Ushna and Sheeta 
Virya; Madhur and Katu Vipaka; Tridosha 
shamaka and with Medhya and Balya properties. 
Madhura rasa is Sarvadhatu Vardhaka, 
Balya, Brimhana, Jeevaniya, Preenana and 
Sthairyakarana. Madhur rasa is formed by 
composition of Prithvi and Jala mahabhuta. The 
panchabhautika composition of Mansa dhatu 
resembles to Madhura rasa. Hence by the law of 
Samanyam Vridhikarnam, Madhura rasa helps in 
the growth & proper nourishment of muscular 
tissue. By virtue of Sarvadhatu vardhaka 
property, Madhura rasa is capable of providing 
support and proper nourishment to neurons in 
order to take up load of already damaged 
neurons. Madhura rasa along with Tikta and 
Katu rasa may help in the proper development of 
neuron synapses and thereby generating a 
process of regeneration in neuronal precursor 
cells. Katu rasa is responsible for Indriya 
utojetaka (to stimulate sensory/motor organs to 
perceive their subject), Agnidipana (secretion of 
hormones in synaptic vesicles) Margana 
vivraunati (to create new pathway for proper 
functioning and replacement of damaged 
neurons) so it can be postulated that it may 
provide stimulus in the regions of brain where 
cells are capable of regenerating especially 
hippocampal region.  
Ushna virya helps to increase the blood 
circulation in brain while Sheeta virya with 
Stambhana and Sthirikarana property may 
restrict the excessive neuronal discharge that is 
seen in case of convulsions.  
Madhur vipaka is said to increase all the 
Sharira dhatu including brain and muscular 
tissues. Katu vipaka on the other hand increases 
the overall metabolism in the body, proper 
enzymatic secretions, thereby minimizing the 
nutrients deficiencies and stimulates all sense 
organs to perceive their respective objects.  
The effect of Syp. Ayurvedic Compound 
can be further postulated on principles of 
modern perspective as follows: 
i. Drugs capable of Regenerating Neurons are 
Mandookparni which has shown increase in 
length of dendrites of Amygdaloid 
neurons;[4] Nerve regeneration;[5] and 
Hippocampal CA3 neuronal dendritic 
arborization & neuroprotective effect.[6] 
Ashwagandha has shown effect on Induction 
of Axon or Dendritic outgrowth;[7] Neuron 
regeneration and synaptic 
reconstructions.[8] 
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ii. Drugs having Neuroprotective role are 
Jatamansi;[9] Mandookparni;[6] 
Ashwagandha; [10] Vacha;[11] Pippali;[12] 
Yasthimadhu;[13] Kapikacchu.[14] 
iii. Drugs having Anti convulsant action are 
Jatamansi;[15] Ashwagandh;[16] Yasthimadhu. 
[17] 
iv. Drugs showing effect on cognition, learning 
and memory are Jatamansi;[18] Brahmi;[19] 
Mandookparni;[15] Vacha;[20] Guduchi;[21] 
Yasthimadhu.[22,23] 
v. Drugs having Balya and Brimhana effect are 
Bala, Vidarikanda, Ashwagandha and 
Kapikacchu. 
Effect of Abhyanga: The Abhyanga was carried 
out with Kshirbala taila. The effect of Abhyanga 
can be assumed in two way i.e. physical 
manipulations and the effect of medicated oil. 
The ingredients of Kshirbala taila are Bala, Tila 
taila and Godugdha. Bala is Vatashamak and 
Balya that absorbed locally with the help of oil 
media provides nutrition to muscular tissue 
preventing from atrophy of muscles and 
improving muscular tone.  
The main part of Abhyanga procedure is 
the mechanical stimulation more precisely the 
pressure application during massage therapy. 
Pressure application done in proper way can 
help in reduction of motor neurone 
hyperexcitability by reducing the alpha motor 
neuron activity. The way of mechanism of action 
is not clearly understood and the amount of 
pressure to be given to stimulate deep tendon 
receptors or superficial mechanoreceptors is still 
not properly understood. A study reported that 
in hemiparetic subjects the H-reflex was 
depressed during both continuous and 
intermittent tendon pressure. Intermittent 
pressure was more effective than continuous. 
[24,25] In a study, cerebral palsy symptoms in 
children were decreased following massage 
therapy but the mechanism behind it was not 
explained in the study.[26] In this way Abhyanga 
acts through the properties of Sneha as discussed 
above that help to encounter vitiated Vata.  
Effect of Shastik Sali Pinda Sweda - Shastik rice 
(Oryza sativa linn.) is Snigdha, Bala vardhana and 
Deha dardhyakrita. Bala and Godugdha used to 
cook the Shastik sali and to heat the bolus is 
Snigdha, Balya, Rasayana and Vatahara. The heat 
provided by bolus of Shastik sali dipped in 
Balamula kwatha with Godugdha may increase 
the blood flow locally, relieve muscle spasm, 
increase tendon extensibility and provide pain 
relief. Bala absorbed locally provides 
nourishment to muscular tissue and prevents 
from emaciation.  
Thus combined effect of Abhyanga and 
Shastik shali pinda sweda along with 
Physiotherapy helps in reducing spasticity, 
facilitating the free movement of the joints and 
preventing from development of deformities and 
contractures. It also provides nutrition to 
muscular tissue thereby preventing from 
atrophy and detrimental changes.  
Effect of Matra Basti – Basti is being the most 
widely used and highly effective treatment 
modality for treating neurological disorders. The 
pharmacodynamical action of Basti in alleviating 
symptoms of neurological manifestation in exact 
way is still not clearly understood. The 
ingredients of Kshirbala taila are Vatashamak 
and Balya. It counteracts the vitiated Vata at root 
level of its origin thereby normalizing and 
influencing its sub doshic level at other distant 
sites too. This mode of action can be explained 
on concepts of System biology. The theory says 
that all organs are interconnected or inter- 
related functionally with each other at molecular 
level directly or indirectly. Thereby 
pathophysiological alteration at one level results 
into change at another level. The gastro 
intestinal tract has rich network of nerve fibres 
known as enteric nervous system and it works in 
synergism with central nervous system. Thus the 
effect of Basti at gastrointestinal system will 
definitely affect other system thereby achieving a 
level of homeostasis. Thus it helps to control and 
regulate symptoms of cerebral palsy. 
Effect of Shirodhara – In a study the psycho – 
neuro - immunologic changes of Shirodhara was 
studied. The results showed that Shirodhara has 
anxiolytic and Altered state of consciousness -
inducing effects, and it promotes a decrease of 
noradrenaline and exhibits a sympatholytic 
effect, resulting in the activation of peripheral 
foot skin circulation and immunopotentiation.[27] 
Thus chemical constituent of Shirodhara may 
modulate the secretions of various 
neurotransmitter and hormone thereby 
controlling seizures, cognitive impairment and 
behavioral problems like anxiety, attention – 
deficit hyperactivity disorder etc. associated with 
cerebral palsy 
CONCLUSION 
The overall result notes that the effect of 
Physiotherapy is potentiated by Ayurvedic 
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procedures and Syp. Ayurvedic Compound (with 
properties of Medhya, Balya and Brihmana) for 
better reduction in spasticity, prevention of joint 
deformities and contractures and thereby, 
promoting for early achievement in areas of ADL 
by improving muscle tone, gain in muscle 
strength, proper nourishment of Dhatus and 
intelligence for better skill performance.  
The study suggest for further extensive 
researches in areas of application of Panchkarma 
procedures like Abhyanga, Shastik Sali pinda 
sweda, Shirodhara and Basti for understanding 
better way of mechanism with the help of 
modern medical aids like EMG, EEG etc.  
REFERENCES 
1. Bottos M, Granato T, Allibrio G. Prevalence 
of cerebral palsy. Ger-Med-Child-Neurol. 
1999;41(1):26-39. 
2. Koterazawa-K, Nabetani-M, Miyata-H, 
Kodama-S, Takada- S. Incidence of cerebral 
palsy. No-To-Hattatsu.1998;30(6): 489-93. 
3. Loewen SC; Anderson BA. Reliability of the 
modified motor assessment scale and the 
Barthel index. Phys Ther. 1988;68(7):1077-
81. 
4. K.G.Mohandas Rao, S.Muddanna Rao and 
S.Gurumadhva Rao. Enhancement of 
Amygdaloid Neuronal Dendritic 
Arborization by Fresh Leaf Juice of Centella 
asiatica (Linn) During Growth Spurt Period 
in Rats. Oxford Journals Medicine Evidence-
based Compl. and Alt. Medicine. 
2007;6(2):203-210.  
5. Amala Soumyanath, Yong-Ping Zhong, 
Xiaolin Yu, Dennis Bourdette, Dennis R. 
Koop, Sandra A. Gold, et al. Centella asiatica 
accelerates nerve regeneration upon oral 
administration and contains multiple active 
fractions increasing neurite elongation in-
vitro. Journal of Pharmacy and 
Pharmacology. Volume 57 Issue 
9, Pages 1221 – 1229. 
6. Lee MK, Kim SR, Sung SH, Lim D, Kim H, 
Choi H, et al.Asiatic acid derivatives protect 
cultured cortical neurons from glutamate 
induced neurotoxicity. Res Commun Mol 
Pathol Pharmacol. 2000; 108 (1-2): 75-86. 
7. Tohdha, Chihiro. Dendrite extension by 
methanol extract of Ashwagandha (roots of 
Withania somnifera) in SK-N-SH cells. 
Neuropharmacology. 2000;11(9);1981-
1985. 
8. Kuboyama T, Tohda C, Zhao J, Nakamura N, 
Hattori M, Komatsu K. Axon – or dendrite 
predominant outgrowth induced by 
constituents from Ashwagandha. 
Neuroreport 2002;13(14):1715-20. 
9. Salim S, Ahmad M, Zafar KS, Ahmad AS, 
Islam F. Protective effect of Nordostachys 
jatamansi in rat cerebral ischemia. 
Pharmacol. Biochem Behav. 
2003;74(2):481-6 
10. Sushma Jain, Sunil Dutt Shukla, Kanika 
Sharma, Maheep Bhatnagar. 
Neuroprotective Effects of Withania 
somnifera Dunn. in Hippocampal Sub-
regions of Female Albino Rat. Phytotherapy 
Research. 2001;15(6):544–548. 
11. S.R. Yende, U.N.Harle, V.V.Bore, A.O.Bajaj, 
K.K.Shroff, Y.D.Vetal. Reversal of 
neurotoxicity induced cognitive impairment 
associated with phenytoin and 
phenobarbital by acorus calamus in mice. 
Journal of Herbal Medicine and Toxicology 
2009; 3(1):111-115  
12. Min Fu, Zhao-hui Sun and Huan-cong Zuo. 
Neuroprotective Effect of Piperine on 
Primarily Cultured Hippocampal Neurons. 
Biological & Pharmaceutical Bulletin. 2010; 
33(4):598 
13. P. Muralidharan, G. Balamurugan, Venu 
Babu. Cerebroprotective effect of 
Glycyrrhiza glabra Linn. root extract on 
hypoxic rats. Bangladesh J Pharmacol. 
2009;4:60-64. 
14. T. Maheswaria, D. Vijayrajaa, R. Kundhavai 
Natchiyara, K. Kalaivania, S. Rajasankarb K. 
Tamilselvama, T. Manivasagama. Synergistic 
neuropreventive effect of withania 
somnifera root powder and mucuna pruriens 
seed powder in parkinsonic mice model. 
Journal of Herbal Medicine and Toxicology. 
2010;4(2)63-69. 
15. Rao VS, Rao A, Karanth KS. Anticonvulsant 
and neurotoxicity profile of Nardostachys 
jatamansi in rats. J Ethnopharmacol 
2005;6:102:351. 
16. Kulkarni, S K Akula, Kiran Kumar Dhir, 
Ashish. Effect of Withania somnifera Dunal 
root extract against pentylenetetrazol 
seizure threshold in mice: Possible 
involvement of GABAergic system. IJEB 
2008;46(06). 
17. Nassiri-Asl, M., Saroukhani and F. 
Zamansoltani. Anticonvulsant effects of 
aqueous extract of Glycyrrhiza glabra root in 
Choudhary Kuldeep R et al. Ayurvedic Management for Improving Activities of Cerebral Palsy  
 Available online at : http://ijapr.in Page 79 
PTZ-induced seizure in mice. Int. J. 
Pharmacology.2007;3:432-434. 
18. Hanumanthachar Joshi, Dr.Milind Parle. 
Nardostachys jatamansi Improves Learning 
and Memory in Mice. Journal of Medicinal 
Food. Mar 2006, Vol. 9, No. 1:113-118. 
19. Roodenrys S, Booth D, Bulzomi S, Phipps A, 
Micallef C, Smoker J. Chronic effects of 
Brahmi (Bacopa monniera) on human 
memory. Neuropsychopharmacology. 2002; 
27(2):279-81. 
20. Dey C.D, Bose S and Mitra S. Effect of some 
centrally active phytoproducts on maze-
learning of albino rats. Indian J. Physiol 
Allied Sci.1976;30:88-90. 
21. Ashutosh Agrawal, et al. Effect Of Tinospora 
Cordifolia On Learning And Memory In 
Normal And Memory Deficit Rats: Indian 
Journal of Pharmacology 2002;34:339-349.  
22. Dinesh Dhingra and Amandeep Sharma. 
Antidepressant-like activity of Glycyrrhiza 
glabra L. in mouse models of immobility 
tests. Progress in Neuro-
Psychopharmacology and Biological 
Psychiatry. 2006;30(3):449-454.  
 
23. Dinesh Dhingra, Milind Parle, S.K. Kulkarni. 
Comparative Brain Cholinesterase-
Inhibiting Activity of Glycyrrhiza glabra, 
Myristica fragrans, Ascorbic Acid, and 
Metrifonate in Mice Journal of Medicinal 
Food. Summer. 2006;9(2): 281-283.  
24. Kukulka CG, Fellows WA, Oehlertz JE, 
Vanderwilt SG. Effect of tendon pressure on 
alpha motoneuron excitability. Phys Ther. 
1985;65:595. 
25. Kukulka CG, Beckman SM, Holte JB, 
Hoppenworth PK. Effects of intermittant 
tendon pressure on alpha motoneuron 
excitability. Phys Ther. 1986;66:1091-1094 
26. Maria Hernandez-Reif, Tiffany Field, Shay 
Largie, Miguel Diego, Natasha Manigat, 
Jacqueline Seoanes, et al. Cerebral palsy 
symptoms in children decreased following 
massage therapy, Early Child Development 
and Care. 2005;175(5):445–456. 
27. Kazuo Uebaba, Feng-Hao Xu, Hiroko 
Ogawa,Takashi Tatsuse, B.C.,Bing-Hong 
Wang, Tatsuya Hisajima, et al. 
Psychoneuroimmunologic Effects of 
Ayurvedic Oil-Dripping Treatment. The 
journal of alternative and complementary 
medicine. 2008;14(10): 1189–1198. 
 
 
  
Cite this article as:  
Choudhary Kuldeep R, Abhimanyu Kumar. A Clinical Study to 
Evaluate Role of Ayurvedic Management for Improving 
Activities of Daily Living in Cerebral Palsy Affected Children. 
Int. J. Ayur. Pharma Research. 2014;2(4):68-82. 
Source of support: Nil, Conflict of interest: None Declared 
 
*Address for correspondence 
Dr. Choudhary Kuldeep R 
Lecturer 
Sri Satya Sai Murlidhar Ayurvedic  
Medical College and Hospital 
Dune- Ke, G.T. Road Moga (142001) 
Punjab, India. 
Phone:  +919461627760 
                +918198865710 
E-mail:  kuldeepall@yahoo.co.in  
 Int. J. Ayur. Pharma Research, 2014; 2(4): 68-82  ISSN: 2322 - 0910 
 
 Available online at : http://ijapr.in Page 80 
GRAPHS 
Graphs showing effect of therapy in particular item of Modified Barthel Index 
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